The sales reported in this Form 4 were affected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person on March 20, 2013.
This transaction was executed in multiple trades at prices ranging from $30.04 to $32.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
The above information was disclosed in a filing to the SEC. To see this filing in its entirety, click here.
To receive a free e-mail notification whenever HealthStream makes a similar move, sign up!
Other recent filings from the company include the following:
Healthstream Announces First Quarter 2014 Results - April 21, 2014
Additional definitive proxy soliciting materials and Rule 14(a)(12) material - April 18, 2014
Other definitive proxy statements - April 18, 2014